Europe just approved a combined flu and COVID shot. Why hasn’t the US?

On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for authorization by European regulators, which opens the door for the vaccine’s approval in the European Union. The European Medicines Agency, the regulator granting the recommendation (or adopting a “positive opinion” on recommending it for market authorization), said that the messenger RNA vaccine should help protect “people aged 50 years and older against COVID-19 and seasonal influenza (flu),” in a statement.  The shot works like any other vaccine, effectively prepping the human body to defend ...